Nanopharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Nanopharmaceuticals

Access the complete profile.

Nanopharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5411 Legal Services
Address	1 Discovery Dr Ste 232 Rensselaer, NY 12144

Note: Revenues for privately held companies are statistical evaluations.


Nanopharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Nanopharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Nanopharmaceuticals is classified as operating in the Legal Services industry, NAICS Code 5411.

Nanopharmaceuticals Annual Revenue and Growth Rate

Nanopharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Nanopharmaceuticals's revenues are gauged from an analysis of company filings.

Nanopharmaceuticals's Income Statement (based on Industry Averages)

Nanopharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Nanopharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
August 20, 2018	8	N/A	$0 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Nanopharmaceuticals is developing and marketing. Nanopharmaceuticals doesn't have any recent trademark applications, indicating Nanopharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NANO-DIAMINO-TETRAC Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in in vivo diagnostic; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patch	06/29/2015
NANOTRIAC Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in vivo diagnostic use; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patch	02/07/2014
NANOTETRAC Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in vivo diagnostic use; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patch	02/07/2014

See all trademarks and details in the Full Report.

Market Share of Nanopharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nanopharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to Nanopharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SCHILLER KNAPP LEFKOWITZ & HERTZEL	Latham, NY	100
MIR SCIENTIFIC	Rensselaer, NY	56
LAVELLE & FINN	Latham, NY	44
ROWLANDS LEBROU & GRIESMER PLL	Latham, NY	43
EHRLICH & ARCODIA PC	Troy, NY	42
E STEWART JONES HACKER MURPHY	Troy, NY	36

Future Competition: Nanopharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Nanopharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)